On April 26, 2005, the FDA and drug company Pfizer notified health care professionals of Pfizer's voluntary recall of one lot (40,000 bottles) of 100 milligram capsules of the epilepsy medication Neurontin.

Pfizer issued the recall after a mechanical failure in the manufacturing process resulted in some bottles containing empty or partially filled capsules.  Warnings were issued due to the possibility that patients taking Neurontin to control epilepsy could experience seizures from a missed dose of the product.

Click here to find Neurontin Attorneys near you.